Pulmonx (LUNG) Interest & Investment Income (2019 - 2025)
Pulmonx (LUNG) reported Interest & Investment Income of $611000.0 for Q3 2025, down 51.85% year-over-year from $1.3 million in Q3 2024, and down 15.49% on a QoQ basis from $723000.0 in Q2 2025.
Pulmonx (LUNG) has 7 years of Interest & Investment Income data on file, last reported at $611000.0 in Q3 2025.
- Quarterly Interest & Investment Income fell 51.85% year-over-year to $611000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $3.2 million (down 41.64% YoY) and the FY2024 annual result came in at $5.1 million, down 9.11% from the prior year.
- Interest & Investment Income slipped to $611000.0 in Q3 2025 per LUNG's latest filing, from $723000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $1.5 million in Q4 2023 and bottomed at $94000.0 in Q4 2021.
- The 5-year median for Interest & Investment Income is $748000.0 (2022), against an average of $776631.6.
- The widest annual swing landed in 2021, when Interest & Investment Income jumped 1000.0%; it then sank 51.85% in 2025.
- Tracing LUNG's Interest & Investment Income over 5 years: stood at $94000.0 in 2021, then jumped by 695.74% to $748000.0 in 2022, then jumped by 106.02% to $1.5 million in 2023, then slumped by 32.19% to $1.0 million in 2024, then sank by 41.53% to $611000.0 in 2025.
- Per Business Quant, the three latest LUNG Interest & Investment Income figures stand at $611000.0 (Q3 2025), $723000.0 (Q2 2025), and $864000.0 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -25.76 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Pulmonx | 67.30 Mn | -2.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 611,000.00 |
| Jun 30, 2025 | 723,000.00 |
| Mar 31, 2025 | 864,000.00 |
| Dec 31, 2024 | 1.05 Mn |
| Sep 30, 2024 | 1.27 Mn |
| Jun 30, 2024 | 1.31 Mn |
| Mar 31, 2024 | 1.44 Mn |
| Dec 31, 2023 | 1.54 Mn |
| Sep 30, 2023 | 1.49 Mn |
| Jun 30, 2023 | 1.41 Mn |
| Mar 31, 2023 | 1.13 Mn |
| Dec 31, 2022 | 748,000.00 |
| Sep 30, 2022 | 477,000.00 |
| Jun 30, 2022 | 199,000.00 |
| Mar 31, 2022 | 105,000.00 |
| Dec 31, 2021 | 94,000.00 |
| Sep 30, 2021 | 99,000.00 |
| Jun 30, 2021 | 102,000.00 |
| Mar 31, 2021 | 105,000.00 |
| Dec 31, 2020 | 115,000.00 |
| Sep 30, 2020 | 9,000.00 |
| Jun 30, 2020 | 15,000.00 |
| Mar 31, 2020 | 74,000.00 |
| Dec 31, 2019 | 122,000.00 |
| Sep 30, 2019 | 167,000.00 |